Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical...

Area of Science:

• Pulmonology
• Pediatric Respiratory Medicine

Background:

• Bronchiectasis incidence is rising globally, contributing significantly to chronic lung disease.
• Management strategies for pediatric bronchiectasis are limited, particularly evidence-based approaches.
• Personalized management plans have improved outcomes in other respiratory diseases.

Purpose of the Study:

• To review the literature for evidence on the effectiveness of personalized written bronchiectasis action management plans (BAMPs) in children.
• To identify any published studies evaluating BAMPs for pediatric bronchiectasis.

Main Methods:

• A systematic literature search was conducted to find relevant studies.
• Articles were screened based on titles, abstracts, and full texts.
• Studies were excluded if they did not specifically address BAMPs in children with bronchiectasis.

Main Results:

• The literature search identified 43 articles, with 39 excluded after initial screening.
• Only four full-text articles were reviewed and subsequently excluded.
• No published studies were found that evaluated the use of BAMPs in children with bronchiectasis.

Conclusions:

• There is currently no published evidence to support the use of BAMPs for improving clinical outcomes in children with bronchiectasis.
• A significant clinical research gap exists regarding the efficacy of BAMPs in pediatric bronchiectasis.
• Until high-quality research is available, clinicians should follow existing national and international guidelines for managing pediatric bronchiectasis.